Literature DB >> 2511563

Clinical evaluation and cost effectiveness of preoperative laboratory assessment on patients undergoing total hip arthroplasty.

D P Sanders1, F W McKinney, W H Harris.   

Abstract

By examining the records of 101 admissions (86 patients) undergoing total hip replacement for osteoarthritis, we studied the impact of 24 preoperative laboratory assessments on the postoperative course. Four patients had their procedures postponed or canceled because of laboratory abnormalities; three of these patients had abnormal urinalyses and one had abnormal liver function tests. No other patients had alterations in their perioperative course as a result of the tests. No subsequent postoperative complications were attributable to either an abnormal or deficient preoperative assessment. Two patients with postoperative hepatitis had normal preoperative liver function studies. One patient had a postoperative bleeding episode but had had normal preoperative PT and PTT values. The economic implications are discussed in a cost-effectiveness model. On the basis of these results, we recommend that only a minimal set of preoperative laboratory tests be added to the detailed medical history and physical examination in otherwise healthy patients about to undergo total hip replacement surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2511563     DOI: 10.3928/0147-7447-19891101-09

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  2 in total

1.  Usefulness of Perioperative Laboratory Tests in Total Hip and Knee Arthroplasty: Are They Necessary for All Patients?

Authors:  Marc R Angerame; David C Holst; Alexandria Phocas; Michael A Williams; Douglas A Dennis; Jason M Jennings
Journal:  Arthroplast Today       Date:  2021-01-30

2.  Outcomes of Unilateral Total Hip Arthroplasty in Patients Aged Under 35 Years in Iranian Population: A Preliminary Study.

Authors:  Mahdi Motififard; Ali Andalib; Seyed Jalil Hamidi; Sajad Badiei
Journal:  Adv Biomed Res       Date:  2018-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.